Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Current Assets (2023 - 2025)

Historic Current Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $208.1 million.

  • Tonix Pharmaceuticals Holding's Current Assets rose 31167.13% to $208.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.1 million, marking a year-over-year increase of 31167.13%. This contributed to the annual value of $119.0 million for FY2024, which is 14912.49% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Current Assets stood at $208.1 million, which was up 31167.13% from $143.5 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Current Assets high stood at $208.1 million for Q3 2025, and its period low was $25.3 million during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Current Assets averaged around $85.5 million, with its median value being $51.3 million (2023).
  • Per our database at Business Quant, Tonix Pharmaceuticals Holding's Current Assets tumbled by 6405.18% in 2024 and then surged by 46762.37% in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Current Assets (Quarter) stood at $47.8 million in 2023, then soared by 149.12% to $119.0 million in 2024, then skyrocketed by 74.85% to $208.1 million in 2025.
  • Its last three reported values are $208.1 million in Q3 2025, $143.5 million for Q2 2025, and $149.6 million during Q1 2025.